OptimizeRx (OPRX) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Citizens | Maintained | Market Outperform | $11.00 from $9.00 | Aug 14, 2026 |
| Stifel | Maintained | Buy | $14.00 from $17.00 | May 13, 2026 |
| Stephens & Co. | Maintained | Equal-Weight | $7.00 from $10.00 | May 13, 2026 |
| B. Riley Securities | Maintained | Buy | $10.00 from $11.00 | May 13, 2026 |
| Lake Street | Maintained | Buy | $11.00 from $20.00 | May 13, 2026 |
| Stifel | Maintained | Buy | $17.00 from $21.00 | Mar 6, 2026 |
| Stephens & Co. | Maintained | Equal-Weight | $10.00 from $17.00 | Mar 6, 2026 |
| B. Riley Securities | Maintained | Buy | $11.00 from $28.00 | Mar 6, 2026 |
| Roth Capital | Maintained | Buy | $18.00 from $32.00 | Mar 6, 2026 |
| Lake Street | Maintained | Buy | $20.00 from $24.00 | Mar 6, 2026 |
| Stephens & Co. | Maintained | Equal-Weight | $17.00 from $20.00 | Nov 17, 2025 |
| Citizens | Maintained | Market Outperform | $24.00 from $23.00 | Nov 7, 2025 |
| JMP Securities | Maintained | Market Outperform | $23.00 from $20.00 | Oct 10, 2025 |
| JMP Securities | Maintained | Market Outperform | $20.00 from $14.00 | Aug 11, 2025 |
| Stifel | Maintained | Buy | $18.00 from $16.00 | Aug 8, 2025 |
| Stifel | Maintained | Buy | $16.00 from $12.50 | Jun 9, 2025 |
| JMP Securities | Maintained | Market Outperform | $14.00 from $11.00 | May 13, 2025 |
| Stifel | Maintained | Buy | $12.50 from $8.00 | May 13, 2025 |
| JMP Securities | Maintained | Market Outperform | $8.00 | Feb 6, 2025 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $6.00 from $7.00 | Jan 8, 2025 |
Frequently asked questions
Is OPRX a buy, sell, or hold?
Analysts covering OptimizeRx currently average a Buy rating: 6 buy, 0 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on OPRX?
On Aug 14, 2026, Citizens maintained OptimizeRx at Market Outperform with a price target of $11.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.